Corrigendum: Structure-guided design of a potent Clostridioides difficile toxin A inhibitor

Front Microbiol. 2023 Mar 30:14:1167817. doi: 10.3389/fmicb.2023.1167817. eCollection 2023.

Greg Hussack¹, Martin A Rossotti¹, Henk van Faassen¹, Tomohiko Murase², Luiz Eugenio², Joseph D Schrag³, Kenneth K-S Ng^{2

4}, Jamshid Tanha^{1

5}

¹ Life Sciences Division, Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.
² Department of Biological Sciences, University of Calgary, Calgary, AB, Canada.
³ Life Sciences Division, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.
⁴ Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, Canada.
⁵ Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

Abstract

[This corrects the article DOI: 10.3389/fmicb.2023.1110541.].

Keywords: Clostridioides difficile; VHH; biparatopic; inhibitor; nanobody; single-domain antibody; toxin.